Anthem Inc (ANTM):企業の財務・戦略的SWOT分析

◆英語タイトル:Anthem Inc (ANTM) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDFS25012FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:63
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Anthem Inc (ANTM) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Anthem Inc (Anthem), is a health benefits company. The company offers managed healthcare related products and administrative services. The company provides various specialty and insurance products and services including radiology benefit management, pharmacy benefits management, dental, life and disability insurance benefits, and analytics-driven personal health care. Anthem offers its products and services to large and small groups, federal government, Medicaid and Medicare markets, and individuals. Its various types of medical membership customers include Local Group, Individual, National Accounts, BlueCard, Medicare, Medicaid, and Federal Employees Health Benefits (FEHB). The company is an independent licensee of the Blue Cross and Blue Shield Association (BCBSA) and has license for insurance operations across the US. Anthem is headquartered in Indianapolis, Indiana, the US.

The company reported net premiums written of US$105,726 million for the fiscal year ended December 2020 (FY2020), an increase of 11.6% over that in FY2019.

Anthem Inc Key Recent Developments

Feb 08,2021: Anthem to Host Virtual Investor Day Conference on March 3, 2021
Jan 27,2021: Anthem reports fourth quarter and full year 2020 results
Dec 16,2020: Anthem names Dr. Shantanu Agrawal chief health officer
Oct 28,2020: Anthem reports third quarter results, reaffirms commitment to stakeholders during covid-19 pandemic
Sep 18,2020: Anthem announces solar power purchase agreement to move company closer towards 100 percent renewable energy goal

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Anthem Inc – Key Facts
Anthem Inc – Key Employees
Anthem Inc – Key Employee Biographies
Anthem Inc – Major Products and Services
Anthem Inc – History
Anthem Inc – Company Statement
Anthem Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Anthem Inc – Business Description
Business Segment: Commercial & Specialty Business
Overview
Performance
Business Segment: Government Business
Overview
Performance
Business Segment: IngenioRx
Overview
Performance
Business Segment: Other
Overview
Performance
Anthem Inc – Corporate Strategy
Anthem Inc – SWOT Analysis
SWOT Analysis – Overview
Anthem Inc – Strengths
Anthem Inc – Weaknesses
Anthem Inc – Opportunities
Anthem Inc – Threats
Anthem Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Anthem Inc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Feb 08, 2021: Anthem to Host Virtual Investor Day Conference on March 3, 2021
Jan 27, 2021: Anthem reports fourth quarter and full year 2020 results
Dec 16, 2020: Anthem names Dr. Shantanu Agrawal chief health officer
Oct 28, 2020: Anthem reports third quarter results, reaffirms commitment to stakeholders during covid-19 pandemic
Sep 18, 2020: Anthem announces solar power purchase agreement to move company closer towards 100 percent renewable energy goal
Sep 16, 2020: Anthem announces research study with apple watch to help improve asthma management
Sep 10, 2020: Anthem, Ascension Wisconsin partner to offer ACA Health Plans in 2021
Sep 02, 2020: Anthem affiliated health plans more than doubled the number of consumers receiving whole-person treatment for opioid use disorder
Aug 17, 2020: Anthem and Quest Diagnostics form strategic relationship
Jun 11, 2020: Anthem leads collaboration to develop tools to help public officials and businesses make informed decisions Related to COVID-19
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Anthem Inc, Key Facts
Anthem Inc, Key Employees
Anthem Inc, Key Employee Biographies
Anthem Inc, Major Products and Services
Anthem Inc, History
Anthem Inc, Subsidiaries
Anthem Inc, Key Competitors
Anthem Inc, Ratios based on current share price
Anthem Inc, Annual Ratios
Anthem Inc, Annual Ratios (Cont...1)
Anthem Inc, Interim Ratios
Anthem Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Anthem Inc (ANTM):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Middleby Corp (MIDD):企業の財務・戦略的SWOT分析
    The Middleby Corp (MIDD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Trianni Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Trianni Inc (Trianni) is a developer of fully human monoclonal antibodies that provides its propriety discovery platform. The company provides Trianni Mouse platform that holds engineered versions of three antibody-encoding genetic loci, namely, Heavy, Kappa, Lambda, and others. It enables t …
  • Sonatrach SPA-石油・ガス分野:企業M&A・提携分析
    Summary Sonatrach SPA (Sonatrach) is a state-owned integrated oil and gas company. Its businesses include exploration and production; pipeline transportation; liquefaction, refining and petrochemicals; marketing of petroleum products; maritime transportation; and other services. The company explores …
  • Edison SpA:発電所・企業SWOT分析
    Edison SpA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executi …
  • NovoCure Ltd (NVCR)-製薬・医療分野:企業M&A・提携分析
    Summary NovoCure Ltd (NovoCure) is an drug company that concentrates on the development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in various types of cancer indications such as ovarian cancer, malignant melanoma, hepatocellul …
  • ITOCHU Techno-Solutions Corp (4739):企業の財務・戦略的SWOT分析
    ITOCHU Techno-Solutions Corp (4739) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Ashok Leyland Limited:企業の戦略・SWOT・財務情報
    Ashok Leyland Limited - Strategy, SWOT and Corporate Finance Report Summary Ashok Leyland Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Grid2020 Inc:企業の戦略的SWOT分析
    Grid2020 Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • XTL Biopharmaceuticals Ltd (XTLB):企業の財務・戦略的SWOT分析
    Summary XTL Biopharmaceuticals Ltd (XTL) is a drug development company that focuses on the acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The company’s pipeline products include hCDR1 peptide and recombinant human erythropoietin …
  • Diversicare Healthcare Services Inc (DVCR):企業の財務・戦略的SWOT分析
    Summary Diversicare Healthcare Services Inc (Diversicare), formerly Advocat Inc is a healthcare service provider that offers post acute care services and short term rehabilitation and long-term care services to nursing home patients. The company’s services include life steps rehabilitation program, …
  • Chiyoda Corporation (6366)-石油・ガス分野:企業M&A・提携分析
    Summary Chiyoda Corporation (Chiyoda) is an engineering services provider that offers various services along with its subsidiaries. Its offerings include project management, program management, feasibility studies, front end engineering design works, engineering, procurement, construction, commissio …
  • OJSC Dixy Group:企業の戦略・SWOT・財務情報
    OJSC Dixy Group - Strategy, SWOT and Corporate Finance Report Summary OJSC Dixy Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Vericel Corp (VCEL)-医療機器分野:企業M&A・提携分析
    Summary Vericel Corp (Vericel) formerly Aastrom Biosciences, Inc. is a medical device company that develops patient-specific expanded cellular therapies to repair and regenerate damaged tissue for the treatment of severe, chronic ischemic cardiovascular diseases. It markets two autologous cell thera …
  • Fluxion Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Fluxion Biosciences Inc (Fluxion) is a provider of analytical instruments for functional cellular analyses. The company’s liquid biopsy technologies include IsoFlux CTC liquid biopsy system, ERASE-Seq variant caller for liquid biopsies and the Spotlight 59 for ultra-sensitive NGS mutation de …
  • Panmure Gordon & Co Limited (PMR):企業の財務・戦略的SWOT分析
    Panmure Gordon & Co Limited (PMR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Nobelpharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary NobelPharma Co Ltd (NobelPharma) is a pharmaceutical company that develops medicines for rare diseases and unmet medical needs. The company’s pipeline products include NPC-09, NPC-12, NPC-15, NPC-16, NPC-17 and NPC-18. It offers products in the therapeutic areas of oncology, metabolic diseas …
  • Fusion Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Fusion Pharmaceuticals Inc (Fusion Pharmaceuticals) is a clinical-stage biopharmaceutical company which develops targeted alpha-particle radio therapeutics for the treatment of chemotherapy resistant cancers. Its pipeline product includes FPX-01, a radiolabeled antibody designed to internali …
  • Blackbird Energy Inc (BBI):企業の財務・戦略的SWOT分析
    Summary Blackbird Energy Inc (Blackbird Energy), formerly Blackbird Investments Inc, is an independent oil and gas exploration and development company that acquires, explores, produces and develops oil and gas properties in Western Canada. The company holds interests in Elmworth Project which concen …
  • WAVE Life Sciences Ltd (WVE):企業の財務・戦略的SWOT分析
    Summary Wave Life Sciences Ltd (Wave Life Sciences) formerly WAVE Life Sciences Pte Ltd, discovers, develops and commercializes medicines for genetic diseases. The company's pipeline comprises an mRNA transcript candidates: WVE-120101 and WVE-120102 for Huntington's disease; ATXN3 gene candidate for …
  • Avista Corp (AVA):企業の財務・戦略的SWOT分析
    Avista Corp (AVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆